Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Consolidated Companies, Inc. (INCC) is a public holding company that operates primarily within the wellness and CBD (cannabidiol) sectors. The company focuses on the acquisition and development of brands that utilize hemp-derived compounds to create consumer-facing health products. Its flagship subsidiary, BluDog Products, specializes in the production of CBD-infused water and supplements designed for enhanced bioavailability. INCC targets the growing market for alternative therapies, positioning itself as a consolidator of boutique wellness brands. The company is headquartered in Florida and is traded on the OTC Pink market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Consolidated Companies.